Molecular biophysics

(Redirected from Protein chemistry)

Molecular biophysics is a rapidly evolving interdisciplinary area of research that combines concepts in physics, chemistry, engineering, mathematics and biology.[1] It seeks to understand biomolecular systems and explain biological function in terms of molecular structure, structural organization, and dynamic behaviour at various levels of complexity (from single molecules to supramolecular structures, viruses and small living systems). This discipline covers topics such as the measurement of molecular forces, molecular associations, allosteric interactions, Brownian motion, and cable theory.[2] Additional areas of study can be found on Outline of Biophysics. The discipline has required development of specialized equipment and procedures capable of imaging and manipulating minute living structures, as well as novel experimental approaches.

A ribosome is a biological machine that utilizes protein dynamics

Overview

edit

Molecular biophysics typically addresses biological questions similar to those in biochemistry and molecular biology, seeking to find the physical underpinnings of biomolecular phenomena. Scientists in this field conduct research concerned with understanding the interactions between the various systems of a cell, including the interactions between DNA, RNA and protein biosynthesis, as well as how these interactions are regulated. A great variety of techniques are used to answer these questions.

Fluorescent imaging techniques, as well as electron microscopy, X-ray crystallography, NMR spectroscopy, atomic force microscopy (AFM) and small-angle scattering (SAS) both with X-rays and neutrons (SAXS/SANS) are often used to visualize structures of biological significance. Protein dynamics can be observed by neutron spin echo spectroscopy. Conformational change in structure can be measured using techniques such as dual polarisation interferometry, circular dichroism, SAXS and SANS. Direct manipulation of molecules using optical tweezers or AFM, can also be used to monitor biological events where forces and distances are at the nanoscale. Molecular biophysicists often consider complex biological events as systems of interacting entities which can be understood e.g. through statistical mechanics, thermodynamics and chemical kinetics. By drawing knowledge and experimental techniques from a wide variety of disciplines, biophysicists are often able to directly observe, model or even manipulate the structures and interactions of individual molecules or complexes of molecules.

Areas of Research

edit

Computational biology

edit

Computational biology involves the development and application of data-analytical and theoretical methods, mathematical modeling and computational simulation techniques to the study of biological, ecological, behavioral, and social systems. The field is broadly defined and includes foundations in biology, applied mathematics, statistics, biochemistry, chemistry, biophysics, molecular biology, genetics, genomics, computer science and evolution. Computational biology has become an important part of developing emerging technologies for the field of biology.[3] Molecular modelling encompasses all methods, theoretical and computational, used to model or mimic the behaviour of molecules. The methods are used in the fields of computational chemistry, drug design, computational biology and materials science to study molecular systems ranging from small chemical systems to large biological molecules and material assemblies.[4][5]

Membrane biophysics

edit

Membrane biophysics is the study of biological membrane structure and function using physical, computational, mathematical, and biophysical methods. A combination of these methods can be used to create phase diagrams of different types of membranes, which yields information on thermodynamic behavior of a membrane and its components. As opposed to membrane biology, membrane biophysics focuses on quantitative information and modeling of various membrane phenomena, such as lipid raft formation, rates of lipid and cholesterol flip-flop, protein-lipid coupling, and the effect of bending and elasticity functions of membranes on inter-cell connections.[6]

Motor proteins

edit
 
Kinesin walking on a microtubule is a molecular biological machine using protein domain dynamics on nanoscales

Motor proteins are a class of molecular motors that can move along the cytoplasm of animal cells. They convert chemical energy into mechanical work by the hydrolysis of ATP. A good example is the muscle protein myosin which "motors" the contraction of muscle fibers in animals. Motor proteins are the driving force behind most active transport of proteins and vesicles in the cytoplasm. Kinesins and cytoplasmic dyneins play essential roles in intracellular transport such as axonal transport and in the formation of the spindle apparatus and the separation of the chromosomes during mitosis and meiosis. Axonemal dynein, found in cilia and flagella, is crucial to cell motility, for example in spermatozoa, and fluid transport, for example in trachea. Some biological machines are motor proteins, such as myosin, which is responsible for muscle contraction, kinesin, which moves cargo inside cells away from the nucleus along microtubules, and dynein, which moves cargo inside cells towards the nucleus and produces the axonemal beating of motile cilia and flagella. "[I]n effect, the [motile cilium] is a nanomachine composed of perhaps over 600 proteins in molecular complexes, many of which also function independently as nanomachines...Flexible linkers allow the mobile protein domains connected by them to recruit their binding partners and induce long-range allostery via protein domain dynamics.[7] Other biological machines are responsible for energy production, for example ATP synthase which harnesses energy from proton gradients across membranes to drive a turbine-like motion used to synthesise ATP, the energy currency of a cell.[8] Still other machines are responsible for gene expression, including DNA polymerases for replicating DNA, RNA polymerases for producing mRNA, the spliceosome for removing introns, and the ribosome for synthesising proteins. These machines and their nanoscale dynamics are far more complex than any molecular machines that have yet been artificially constructed.[9]

These molecular motors are the essential agents of movement in living organisms. In general terms, a motor is a device that consumes energy in one form and converts it into motion or mechanical work; for example, many protein-based molecular motors harness the chemical free energy released by the hydrolysis of ATP in order to perform mechanical work.[10] In terms of energetic efficiency, this type of motor can be superior to currently available man-made motors.

Richard Feynman theorized about the future of nanomedicine. He wrote about the idea of a medical use for biological machines. Feynman and Albert Hibbs suggested that certain repair machines might one day be reduced in size to the point that it would be possible to (as Feynman put it) "swallow the doctor". The idea was discussed in Feynman's 1959 essay "There's Plenty of Room at the Bottom".[11]

These biological machines might have applications in nanomedicine. For example,[12] they could be used to identify and destroy cancer cells.[13][14] Molecular nanotechnology is a speculative subfield of nanotechnology regarding the possibility of engineering molecular assemblers, biological machines which could re-order matter at a molecular or atomic scale. Nanomedicine would make use of these nanorobots, introduced into the body, to repair or detect damages and infections. Molecular nanotechnology is highly theoretical, seeking to anticipate what inventions nanotechnology might yield and to propose an agenda for future inquiry. The proposed elements of molecular nanotechnology, such as molecular assemblers and nanorobots are far beyond current capabilities.[15][16]

Protein folding

edit
 
Constituent amino-acids can be analyzed to predict secondary, tertiary and quaternary protein structure.

Protein folding is the physical process by which a protein chain acquires its native 3-dimensional structure, a conformation that is usually biologically functional, in an expeditious and reproducible manner. It is the physical process by which a polypeptide folds into its characteristic and functional three-dimensional structure from a random coil.[17] Each protein exists as an unfolded polypeptide or random coil when translated from a sequence of mRNA to a linear chain of amino acids. This polypeptide lacks any stable (long-lasting) three-dimensional structure (the left hand side of the first figure). As the polypeptide chain is being synthesized by a ribosome, the linear chain begins to fold into its three-dimensional structure. Folding begins to occur even during the translation of the polypeptide chain. Amino acids interact with each other to produce a well-defined three-dimensional structure, the folded protein (the right-hand side of the figure), known as the native state. The resulting three-dimensional structure is determined by the amino acid sequence or primary structure (Anfinsen's dogma).[18]

Protein structure determination

edit

As the three-dimensional structure of proteins brings with it an understanding of its function and biological context, there is great effort placed in observing the structures of proteins. X-ray crystallography was the primary method used in the 20th century to solve the structures of proteins in their crystalline form. Ever since the early 2000s, cryogenic electron microscopy has been used to solve the structures of proteins closer to their native state, as well as observing cellular structures.[19]

Protein structure prediction

edit

Protein structure prediction is the inference of the three-dimensional structure of a protein from its amino acid sequence—that is, the prediction of its folding and its secondary and tertiary structure from its primary structure. Structure prediction is fundamentally different from the inverse problem of protein design. Protein structure prediction is one of the most important goals pursued by bioinformatics and theoretical chemistry; it is highly important in medicine, in drug design, biotechnology and in the design of novel enzymes). Every two years, the performance of current methods is assessed in the CASP experiment (Critical Assessment of Techniques for Protein Structure Prediction). A continuous evaluation of protein structure prediction web servers is performed by the community project CAMEO3D.

The challenge in predicting protein structures is that there lacks a physical model that can fully predict protein tertiary structures from their amino acid sequence. This problem is known as the de novo protein structure prediction problem and is one of the great problems of modern science.[20] AlphaFold, an artificial intelligence program, is able to accurately predict the structures of proteins with genetic homology to other proteins that have been previously solved.[21] Though, this is not a solution to the de novo problem, as it relies on a database of prior data which results in it always being biased.[22] The solution to the de novo protein structure prediction problem must be a purely physical model that will simulate the protein folding in its native environment, resulting in the in silico observation of protein structures and dynamics that were never previously observed.[23]

Spectroscopy

edit

Spectroscopic techniques like NMR, spin label electron spin resonance, Raman spectroscopy, infrared spectroscopy, circular dichroism, and so on have been widely used to understand structural dynamics of important biomolecules and intermolecular interactions.

See also

edit

References

edit
  1. ^ "The goal of Molecular Biophysics". Program in Molecular Biophysics. Johns Hopkins University. Archived from the original on 15 March 2012.
  2. ^ Jackson MB (2006). Molecular and Cellular Biophysics. New York: Cambridge University Press. ISBN 978-1-139-44724-9.
  3. ^ Ouzounis CA (2012). "Rise and demise of bioinformatics? Promise and progress". PLOS Computational Biology. 8 (4): e1002487. Bibcode:2012PLSCB...8E2487O. doi:10.1371/journal.pcbi.1002487. PMC 3343106. PMID 22570600.
  4. ^ "NIH working definition of bioinformatics and computational biology" (PDF). Biomedical Information Science and Technology Initiative. 17 July 2000. Archived from the original (PDF) on 5 September 2012. Retrieved 18 August 2012.
  5. ^ "About the CCMB". Center for Computational Molecular Biology. Providence RI: Brown University. Retrieved 18 August 2012.
  6. ^ Zimmerberg J (April 2006). "Membrane biophysics". Current Biology. 16 (8): R272–R276. Bibcode:2006CBio...16.R272Z. doi:10.1016/j.cub.2006.03.050. PMID 16631568.
  7. ^ Satir P, Christensen ST (June 2008). "Structure and function of mammalian cilia". Histochemistry and Cell Biology. 129 (6): 687–693. doi:10.1007/s00418-008-0416-9. PMC 2386530. PMID 18365235. 1432-119X.
  8. ^ Kinbara K, Aida T (April 2005). "Toward intelligent molecular machines: directed motions of biological and artificial molecules and assemblies". Chemical Reviews. 105 (4): 1377–1400. doi:10.1021/cr030071r. PMID 15826015.
  9. ^ Bu Z, Callaway DJ (2011). "Proteins MOVE! Protein dynamics and long-range allostery in cell signaling". Protein Structure and Diseases. Advances in Protein Chemistry and Structural Biology. Vol. 83. pp. 163–221. doi:10.1016/B978-0-12-381262-9.00005-7. ISBN 9780123812629. PMID 21570668.
  10. ^ Bustamante C, Chemla YR, Forde NR, Izhaky D (2004). "Mechanical processes in biochemistry". Annual Review of Biochemistry. 73: 705–748. doi:10.1146/annurev.biochem.72.121801.161542. PMID 15189157.
  11. ^ Feynman RP (December 1959). "There's Plenty of Room at the Bottom". Archived from the original on 2010-02-11. Retrieved 2017-01-01.
  12. ^ Amrute-Nayak M, Diensthuber RP, Steffen W, Kathmann D, Hartmann FK, Fedorov R, et al. (2010). "Targeted optimization of a protein nanomachine for operation in biohybrid devices". Angewandte Chemie. 49 (2): 312–316. Bibcode:2010AngCh.122..322A. doi:10.1002/ange.200905200. PMID 19921669.
  13. ^ Patel GM, Patel GC, Patel RB, Patel JK, Patel M (February 2006). "Nanorobot: a versatile tool in nanomedicine". Journal of Drug Targeting. 14 (2): 63–67. doi:10.1080/10611860600612862. PMID 16608733. S2CID 25551052.
  14. ^ Balasubramanian S, Kagan D, Hu CM, Campuzano S, Lobo-Castañon MJ, Lim N, et al. (April 2011). "Micromachine-enabled capture and isolation of cancer cells in complex media". Angewandte Chemie. 50 (18): 4161–4164. doi:10.1002/anie.201100115. PMC 3119711. PMID 21472835.
  15. ^ Freitas Jr RA (December 2005). Kasabov N, Havukkala I (eds.). "Current Status of Nanomedicine and Medical Nanorobotics" (PDF). Journal of Computational and Theoretical Nanoscience. 2 (4): 471. Bibcode:2005JCTN....2..471K. doi:10.1166/jctn.2005.001.
  16. ^ Freitas Jr RA, Merkle RC (2006). "Nanofactory Collaboration". Molecular Assembler.
  17. ^ Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walters P (2002). "The Shape and Structure of Proteins". Molecular Biology of the Cell; Fourth Edition. New York and London: Garland Science. ISBN 978-0-8153-3218-3.
  18. ^ Anfinsen CB (July 1972). "The formation and stabilization of protein structure". The Biochemical Journal. 128 (4): 737–749. doi:10.1042/bj1280737. PMC 1173893. PMID 4565129.
  19. ^ Curry S (July 2015). "Structural Biology: A Century-long Journey into an Unseen World". Interdisciplinary Science Reviews. 40 (3): 308–328. Bibcode:2015ISRv...40..308C. doi:10.1179/0308018815Z.000000000120. PMC 4697198. PMID 26740732.
  20. ^ "So Much More to Know". Science. 309 (5731): 78–102. 2005-07-01. doi:10.1126/science.309.5731.78b. ISSN 0036-8075.
  21. ^ Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. (2021-08-26). "Highly accurate protein structure prediction with AlphaFold". Nature. 596 (7873): 583–589. Bibcode:2021Natur.596..583J. doi:10.1038/s41586-021-03819-2. ISSN 0028-0836. PMC 8371605. PMID 34265844.
  22. ^ Terwilliger TC, Liebschner D, Croll TI, Williams CJ, McCoy AJ, Poon BK, et al. (2023-11-30). "AlphaFold predictions are valuable hypotheses and accelerate but do not replace experimental structure determination". Nature Methods. 21 (1): 110–116. doi:10.1038/s41592-023-02087-4. ISSN 1548-7091. PMC 10776388. PMID 38036854.
  23. ^ Dill KA, Ozkan SB, Weikl TR, Chodera JD, Voelz VA (2007-06-01). "The protein folding problem: when will it be solved?". Current Opinion in Structural Biology. Nucleic acids / Sequences and topology. 17 (3): 342–346. doi:10.1016/j.sbi.2007.06.001. ISSN 0959-440X. PMID 17572080.